Reactivate your life and business

Synoptic was created through the need to rapidly innovate due to the pandemic, leveraging years of experience in critical event management to solve rapidly evolving, complex problems with multiple use cases.

Protecting lives

Synoptic are focused on solving the complex web of interconnected problems created by the pandemic. Our unique approach encompasses a micro view of the pandemic from the individuals perspective, whilst simultaneously assessing in real-time the threat posed as a group, whether in the context of a household, workplace or school.

Stopping the virus

There is no single answer to solving the pandemic. There is however an approach that can be taken to address the multitude of elements that can adversely impact life as well as wider society. At Synoptic, we weave the solutions into one logical approach that encompasses technology, testing, track & trace in a safe, secure and private manner.

Creating confidence

The ultimate goal of Synoptic is to create confidence by achieving COVID-19-safe environments through a user-engaged solution. Clarity creates confidence, and we firmly believe the future of the economy requires a user-driven, interconnected solution that each and every one of us can call our own.


Graeme Scott
Graeme ScottChief Executive Officer
With two decades at the forefront of innovation, Graeme founded Synoptic to drive innovation in healthcare in response to the adverse effects of the COVID-19 pandemic. Graeme worked as a think tank for Steve Jobs at Apple in the late ’90s, as well as numerous other clients including BMW and Mini, WB, Universal, Home Depot and Microsoft before developing CarbonWise, an energy-saving software. Once CarbonWise had become a market-leader Graeme sold it and has consistently consulted in technology and risk space, all of which led to the development of Synoptic Software.
Glen Huxley
Glen HuxleyChief Technology Officer
Glen is responsible for the development of the suite of Synoptic healthcare sector products. Glen has over a decade of experience in delivering technological solutions to meet client and business needs. With his knowledge and skills he has created the Synoptic Platform using the latest technologies to create the best possible product. Previously Glen worked at Intuitive, a travel technology company, where he was responsible for building their web booking platform and delivering highly performant and responsive web applications for both the B2B and B2C travel markets. Glen also holds a BSc in Computer Science.
Matt Darwin
Matt DarwinChief Information Officer
Matt is guiding Synoptic’s AI strategy, to further automate and improve Synoptic’s product offerings. He has an Msc in physics, and 17 years experience in the tech industry. Matt joins Synoptic from Oracle, where he led a team of developers building a cloud-native machine learning platform to embed AI into Oracle’s applications. Prior to that, he led software engineering teams in the global telecoms industry. Matt has lived in seven countries, speaks five languages and has been known to wield a polo mallet.
Alexandra D’Arcy Clark
Alexandra D’Arcy ClarkChief Development Officer
Alexandra is responsible for leading Synoptic’s work in the health sector, education and Government. Prior to joining Synoptic Alexandra worked in the travel industry. She specialised in Southern and East Africa and after 7 years in sales, she then moved on to a role in business development which was focussed predominantly in the US. From a development aspect, Alexandra was also constantly proposing new methodologies that allowed the business to adapt in order to attract new potential clients. Alexandra has a BA Hons in History and ran the Marathon des Sables in 2018.
Jacob Dixon
Jacob DixonChief Commercial Officer
Jacob has nearly a decade of experience in the enterprise software industry with a proven record for exceeding quotas & increasing sales while providing excellent customer service and follow-through. Extensive background in new product launch, product management, and new revenue generation. Prior to arriving at Synoptic Software, Jacob helped lead the go to market transformation/strategy at TeamDynamix increasing ARR by 5 million in 24 months and most recently was the top producer of new business revenue in the Non Profit and Public Sector at Salesforce.


Professor Sebastian Johnston
Professor Sebastian JohnstonClinical Covid-19 Specialist Advisor
Sebastian Johnston is Professor of Respiratory Medicine & Allergy at the National Heart & Lung Institute, Imperial College London, and Honorary Consultant Physician in Respiratory Medicine & Allergy at St Mary’s Hospital, Imperial Healthcare NHS Trust, London, as well as Chairman of the Board, Chief Medical Officer and Co-founder of Virtus Respiratory Research. He is Director of the MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, is the Clinical Academic Training Lead for Respiratory Medicine at Imperial College & Imperial Healthcare NHS Trust and is the Asthma UK Clinical Chair. He has been performing respiratory virus-related research including human virus challenge studies in asthma for more than 30 years and is the only investigator worldwide to have performed such studies in people with COPD.
Dr Andrew Coppola
Dr Andrew CoppolaClinical Innovation Advisor & ICU Doctor
Andrew is the clinical innovation lead at Synoptic and unifies clinical knowledge with technological advancement. He holds an MBBS in medicine, BSc in Experimental Pathology and is working towards a Master’s in surgical innovation at Imperial. Having graduated in Medicine at Barts and the London School of Medicine, he has worked as a Foundation Doctor in Intensive Care at the forefront of the COVID19 pandemic. During this time, he has clinically managed and worked at the bedside of the patients most critically unwell with COVID19. He has also led research efforts in describing the demographics and outcomes of these patients in the intensive care, presenting the data to the health care trust. Andrew has also won national and international awards from the Royal Society of Medicine and the International Journal of Surgery for presenting research relating to Critical Care discharge and bladder amyloidosis respectfully.